Built by surgeons, for surgeons.
This platform was not born in a product meeting. It was born in the gap between what surgical candidates need and what currently exists.
A resident preparing for FEBS-SO should not be using the same unfiltered question bank as someone sitting ABSITE. The content requirements are different. The exam format is different. The guideline corpus is different. Yet every platform on the market treats all surgical boards as a single undifferentiated blob.
No single resource covers both US and European certification pathways. Candidates preparing for FEBS specialty boards — HPB, Colorectal, Endocrine, Esophago-Gastric — have essentially no board-specific question bank to practice with. They compile their own materials from textbooks, guideline PDFs, and journal articles, and hope for the best.
SurgBoardsQ&A addresses all of this: board-specific question sets, explanations referenced to current guidelines (ESMO, NCCN, PSOGI, JGCA), automatic weak-area detection, and a single platform that grows as new boards are added.
Board-mapped content
Every question is tagged to a specific board and its official syllabus. Filter by FEBS-SO, ABS-CGSO, ABSITE, or any specialty FEBS exam.
Current guidelines
Explanations cite ESMO, NCCN, PSOGI, and JGCA where applicable. When guidelines change, the explanations change.
Written by a specialist
Questions and explanations are authored by a surgical oncologist with subspecialty expertise in peritoneal malignancy and sarcoma.
Author
Surgical Oncologist · Surgical Oncology
Malignant Peritoneal Disease, Sarcoma and Complex Pelvic Surgery
Sarcoma and Mesenchymal Tumors Section — Asociación Española de Cirujanos (AEC)
Platform created in personal capacity as educator. Does not represent Hospital Gregorio Marañón or UCM.
Every question is written by a single author and mapped to the published syllabus of the board it belongs to. Before publication it must pass an automated check: five options, a written explanation, and a citation — a named society guideline or a named trial. Benign and functional topics cannot be published without a society guideline; oncological ones cite NCCN, ESMO or AJCC, and the classification systems that govern a topic have to appear where they apply. The author has audited the full active bank against current guideline versions, and what fails is re-cited, rewritten or withdrawn.
What this is not. There is no external peer-review panel and no subspecialty diplomate has countersigned the boards outside the author’s own practice, which is surgical oncology — peritoneal malignancy, sarcoma, hepatopancreatobiliary and complex pelvic surgery. Those pages say so on the page itself. What the material offers there is traceability rather than personal authority: every answer names the current source it rests on, so it can be checked before it is trusted. Errors reported through the contact page are corrected or the question is withdrawn.